The online reference source for the interventional NeuroRadiology, Neurology and NeuroSurgery community
Randomized Control Trial Results to be Presented at NANS Jan. 23-26 in Las Vegas; New, Proprietary Differential Target Multiplexed (DTM) Therapy Available on Medtronic Intellis Spinal Cord Stimulation Platform
January 8, 2020
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced a major clinical trial to assess the impact of a ‘Direct to Angio Suite’ workflow on stroke patient outcomes.
November 28, 2019
Promising clinical data for Cascade Net published in the Journal of NeuroInterventional Surgery
October 22, 2019
Montpellier – Sim&Cure is honored and proud to announce last September 17, Sim&Size® obtained U.S.Food and Drug Administration (FDA) 510(k) clearance.
September 27, 2019
Phenox is pleased to announce that it has signed an exclusive distribution agreement with Wallaby Medical Inc. for commercialization of The Avenir™ Detachable Coil System in the U.S. and EU markets.
September 23, 2019
Wallaby Medical announces CE Mark approval and FDA 510(k) clearance of its differentiated embolic coil system, the Avenir Coil System. The intended use for the Avenir Coil System is for endovascular embolization of intracranial aneurysms and other neurovascular abnormalities such as arteriovenous malformations and arteriovenous fistulae. The Avenir Coil System is also intended for arterial and venous embolization in the peripheral vasculature.
September 17, 2019
Watch this clinical case report from a 75 year old female patient presented with NIHSS of 19 presented 4 hours after symptom onset.It was noted that the patient had had a knee implant surgery 3 days prior to her stroke. Additional risk factors included: Coronary Heart Failure, Hypertension, Diabetes, Atrial fibrillation.On admission CT ASPECTS was 10.Imaging confirmed distal left MCA occlusion.
July 31, 2019
DUBLIN and SAN FRANCISCO, July 22, 2019 (GLOBE NEWSWIRE) - Medtronic plc (NYSE:MDT), a global leader in medical technology, and Viz.ai, the emerging leader in applied artificial intelligence (AI) in stroke care, have partnered to accelerate the adoption of Viz.ai’s new technology, which helps synchronize stroke care and decrease time to treatment, potentially improving outcomes for patients.
July 22, 2019
Nashville, TN, May 22, 2019 Vesalio announces it has obtained its second CE Approval spanning multiple new NeVa™ product designs and technology. The new generation NeVa devices expand on the Drop Zone™ and Smart Marker™ technologies while also introducing first to market features such as a distal filter. A controlled launch of the new technology will begin in June in Europe with expected full commercial release in Q4 of this year.
May 22, 2019
Nashville, TN, May 14, 2019 Vesalio announces it has recently raised $5 million in funding. The capital will support the continued global expansion of the NeVa™ Neurothrombectomy System, finance key clinical studies and launch new product introductions.
May 15, 2019